This page is part of the Single Institutional Review Board (sIRB) Implementation Guide (v0.1.0: STU 1 Ballot 1) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
Generated Narrative
identifier: The Questionnaire Response ID for the associated Initiate a Study FHIR Questionnaire Response: QRID-2857 (USUAL), IRB Study Protocol Number assigned by the sIRB's external research study database: SUMC-1234567 (USUAL)
title: Double blind, placebo-controlled trial of a new class of arthritis medication
identifier: id: SUMC-1234567 (USUAL)
name: PlanDef2857
status: draft
status: in-review
category: Interventional Study
keyword: NIH-2021-123456
name: John Doe, IV, MD(OFFICIAL)